tirzepatide oral reviews Pill: FDA-Approved Options 1 and GIP mechanism in a daily Oral Tirzepatide | Daily GLP-1/GIP

Lahoti S, Nashawi M, Sheikh O, Massop D, Mir M, Chilton R (2021) Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond

Weekly dosage schedule Starting dose: 0.25 mg weekly for first 4 weeks Titration phase: 0.5 mg weekly for 4 weeks and then, if tolerated, 1 mg weekly for 4 weeks Maintenance dose for long-term weight management: 1.7 mg once weekly for 4 weeks and then, if tolerated, 2.4 mg once weekly (maximum dose) Dosing considerations If you do not tolerate dose escalation, consult with your healthcare provider and consider delaying the dose escalation for at least 4 weeks

Common side effects may include nausea, vomiting, diarrhea, constipation, and abdominal discomfort

Tirzepatide may be covered under Medicaid when prescribed to treat type 2 diabetes or another health condition

Try eating small, balanced meals regularly